Lidocaine Hydrochloride And Epinephrine Bitartrate
NDC Package 51004-2010-5

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lidocaine Hydrochloride And Epinephrine Bitartrate is a . Marketed by Novocol Pharmaceutical Of Canada, Inc., this product is identified by NDC 51004-2010 and is authorized under FDA application ANDA088390.

Identification & Billing

NDC Package Code
51004-2010-5
Package Description
50 CARTRIDGE in 1 CARTON / 1.7 mL in 1 CARTRIDGE
Product Code
51004-2010
11-Digit Billing Format
51004201005

Clinical Specifications

Proprietary Name
Lidocaine Hydrochloride And Epinephrine Bitartrate
Dosage Form
-

Regulatory & Marketing

Labeler Name
Novocol Pharmaceutical Of Canada, Inc.
FDA Application #
ANDA088390
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-07-2011
End Marketing Date
12-31-2013
Listing Expiration
12-31-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51004-2010-5 identifies a specific commercial package of 50 cartridge in 1 carton / 1.7 ml in 1 cartridge of Lidocaine Hydrochloride And Epinephrine Bitartrate, labeled by Novocol Pharmaceutical Of Canada, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Novocol Pharmaceutical Of Canada, Inc. on November 07, 2011. The current certification is valid through December 31, 2013.

How is this Novocol Pharmaceutical Of Canada, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51004201005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51004-2010-5
11-Digit CMS (5-4-2)
51004-2010-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.